Marco Frigeni
5PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 06, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio
|Jan 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda.Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi
|Mar 23, 2021
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders.Irene Defrancesco, Marcella Visentini, Silvia Zibellini
|Dec 15, 2019
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection.Marco Frigeni, Caroline Besson, Carlo Visco
|Sep 09, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.Luca Arcaini, Caroline Besson, Marco Frigeni
Pageof 1
Frequent Collaborators
3 joint publications
Luca Arcaini
3 joint publications
Michele Merli
2 joint publications
Chiara Cattaneo
2 joint publications
Carlo Visco
2 joint publications
Sara Rattotti
1 joint publications
Caroline Besson
1 joint publications
Hélène Fontaine
1 joint publications
Marco Vignetti
1 joint publications
Marcella Visentini
1 joint publications
Harrys A Torres
